Comments on: High-dose-rate interstitial brachytherapy as monotherapy in one fraction of 20.5 Gy for the treatment of localize prostate cancer: toxicity and 6-years biochemical results.
Journal Article (Letter)
Full Text
Duke Authors
Cited Authors
- Lee, WR
Published Date
- May 2019
Published In
Volume / Issue
- 18 / 3
Start / End Page
- 426 -
PubMed ID
- 30797697
Pubmed Central ID
- 30797697
Electronic International Standard Serial Number (EISSN)
- 1873-1449
Digital Object Identifier (DOI)
- 10.1016/j.brachy.2019.01.009
Language
- eng
Conference Location
- United States